Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Rare susceptibility variants for bipolar disorder suggest a role for G protein-coupled receptors

Abstract

Bipolar disorder (BD) is a prevalent mood disorder that tends to cluster in families. Despite high heritability estimates, few genetic susceptibility factors have been identified over decades of genetic research. One possible interpretation for the shortcomings of previous studies to detect causative genes is that BD is caused by highly penetrant rare variants in many genes. We explored this hypothesis by sequencing the exomes of affected individuals from 40 well-characterized multiplex families. We identified rare variants segregating with affected status in many interesting genes, and found an enrichment of deleterious variants in G protein-coupled receptor (GPCR) family genes, which are important drug targets. Furthermore, we showed targeted downstream GPCR dysregulation for some of the variants that may contribute to disease pathology. Particularly interesting was the finding of a rare and functionally relevant nonsense mutation in the corticotropin-releasing hormone receptor 2 (CRHR2) gene that tracked with affected status in one family. By focusing on rare variants in informative families, we identified key biochemical pathways likely implicated in this complex disorder.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Subramaniam M, Abdin E, Vaingankar JA, Chong SA. Prevalence, correlates, comorbidity and severity of bipolar disorder: results from the Singapore Mental Health Study. J Affect Disord 2013; 146: 189–196.

    Article  Google Scholar 

  2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617–627.

    Article  Google Scholar 

  3. McDonald KC, Bulloch AG, Duffy A, Bresee L, Williams JV, Lavorato DH et al. Prevalence of bipolar I and II disorder in Canada. Can J Psychiatry 2015; 60: 151–156.

    Article  Google Scholar 

  4. Clemente AS, Diniz BS, Nicolato R, Kapczinski FP, Soares JC, Firmo JO et al. Bipolar disorder prevalence: a systematic review and meta-analysis of the literature. Rev Bras Psiquiatr 2015; 37: 155–161.

    Article  Google Scholar 

  5. Mamdani F, Groisman IJ, Alda M, Turecki G. Pharmacogenetics and bipolar disorder. Pharmacogenomics J 2004; 4: 161–170.

    Article  CAS  Google Scholar 

  6. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123C: 48–58.

    Article  Google Scholar 

  7. Alda M, Hajek T, Calkin C, O'Donovan C. Treatment of bipolar disorder: new perspectives. Ann Med 2009; 41: 186–196.

    Article  CAS  Google Scholar 

  8. Cruceanu C, Alda M, Rouleau G, Turecki G. Response to treatment in bipolar disorder. Curr Opin Psychiatry 2011; 24: 24–28.

    Article  Google Scholar 

  9. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet 2013; 381: 1654–1662.

    Article  CAS  Google Scholar 

  10. Neale BM, Sklar P. Genetic analysis of schizophrenia and bipolar disorder reveals polygenicity but also suggests new directions for molecular interrogation. Curr Opin Neurobiol 2015; 30C: 131–138.

    Article  Google Scholar 

  11. Shinozaki G, Potash JB. New developments in the genetics of bipolar disorder. Curr Psychiatry Rep 2014; 16: 493.

    Article  Google Scholar 

  12. Manchia M, Cullis J, Turecki G, Rouleau GA, Uher R, Alda M. The impact of phenotypic and genetic heterogeneity on results of genome wide association studies of complex diseases. PLoS ONE 2013; 8: e76295.

    Article  CAS  Google Scholar 

  13. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008; 40: 695–701.

    Article  CAS  Google Scholar 

  14. Gould TD, Manji HK. Signaling networks in the pathophysiology and treatment of mood disorders. J Psychosomatic Res 2002; 53: 687–697.

    Article  Google Scholar 

  15. Xu X, Muller-Taubenberger A, Adley KE, Pawolleck N, Lee VW, Wiedemann C et al. Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid. Eukaryot Cell 2007; 6: 899–906.

    Article  CAS  Google Scholar 

  16. Alda M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry 2015; 20: 661–670.

    Article  CAS  Google Scholar 

  17. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754–1760.

    Article  CAS  Google Scholar 

  18. Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM et al. An integrated map of genetic variation from 1092 human genomes. Nature 2012; 491: 56–65.

    Article  Google Scholar 

  19. NHLBI GO Exome Sequencing Project (ESP). Available at: http://evs.gs.washington.edu/EVS/.

  20. Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, Kermani BG et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 2010; 327: 78–81.

    Article  CAS  Google Scholar 

  21. Kazius J, Wurdinger K, van Iterson M, Kok J, Back T, Ijzerman AP. GPCR NaVa database: natural variants in human G protein-coupled receptors. Hum Mutat 2008; 29: 39–44.

    Article  CAS  Google Scholar 

  22. Samocha KE, Robinson EB, Sanders SJ, Stevens C, Sabo A, McGrath LM et al. A framework for the interpretation of de novo mutation in human disease. Nat Genet 2014; 46: 944–950.

    Article  CAS  Google Scholar 

  23. Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet 2013; 9: e1003709.

    Article  CAS  Google Scholar 

  24. Nature Reviews Drug Discovery GPCR Questionnaire Participants. The state of GPCR research in 2004. Nat Rev Drug Discov 2004; 3: 575, 577–626.

    Google Scholar 

  25. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995; 92: 836–840.

    Article  CAS  Google Scholar 

  26. Markovic D, Punn A, Lehnert H, Grammatopoulos DK. Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol Endocrinol 2008; 22: 689–706.

    Article  CAS  Google Scholar 

  27. Turecki G, Grof P, Grof E, D'Souza V, Lebuis L, Marineau C et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry 2001; 6: 570–578.

    Article  CAS  Google Scholar 

  28. Grof P, Duffy A, Alda M, Hajek T. Lithium response across generations. Acta Psychiatr Scand 2009; 120: 378–385.

    Article  CAS  Google Scholar 

  29. Cruceanu C, Tan PP, Rogic S, Lopez JP, Torres-Platas SG, Gigek CO et al. Transcriptome sequencing of the anterior cingulate in bipolar disorder: dysregulation of G protein-coupled receptors. Am J Psychiatry 2015; 172: 1131–1140.

    Article  Google Scholar 

  30. Muhleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, Treutlein J et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun 2014; 5: 3339.

    Article  Google Scholar 

  31. Racagni G, Popoli M. Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci 2008; 10: 385–400.

    PubMed  PubMed Central  Google Scholar 

  32. Fries GR, Vasconcelos-Moreno MP, Gubert C, dos Santos BT, Sartori J, Eisele B et al. Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder. Int J Neuropsychopharmacol 2014; 18, pyu043.

    Article  Google Scholar 

  33. Okamoto Y, Shikano S. Phosphorylation-dependent C-terminal binding of 14-3-3 proteins promotes cell surface expression of HIV co-receptor GPR15. J Biol Chem 2011; 286: 7171–7181.

    Article  CAS  Google Scholar 

  34. Maurice P, Guillaume JL, Benleulmi-Chaachoua A, Daulat AM, Kamal M, Jockers R. GPCR-interacting proteins, major players of GPCR function. Adv Pharmacol 2011; 62: 349–380.

    Article  CAS  Google Scholar 

  35. Benovic JL, Kuhn H, Weyand I, Codina J, Caron MG, Lefkowitz RJ. Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci USA 1987; 84: 8879–8882.

    Article  CAS  Google Scholar 

  36. Benzing T, Yaffe MB, Arnould T, Sellin L, Schermer B, Schilling B et al. 14-3-3 interacts with regulator of G protein signaling proteins and modulates their activity. J Biol Chem 2000; 275: 28167–28172.

    CAS  PubMed  Google Scholar 

  37. Bhattacharyya S. Inside story of group I metabotropic glutamate receptors (mGluRs). Int J Biochem Cell Biol 2016; 77(Pt B): 205–212.

    Article  CAS  Google Scholar 

  38. Ayoub MA, Angelicheva D, Vile D, Chandler D, Morar B, Cavanaugh JA et al. Deleterious GRM1 mutations in schizophrenia. PLoS ONE 2012; 7: e32849.

    Article  CAS  Google Scholar 

  39. Frank RA, McRae AF, Pocklington AJ, van de Lagemaat LN, Navarro P, Croning MD et al. Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder. PLoS ONE 2011; 6: e19011.

    Article  CAS  Google Scholar 

  40. Menke A, Samann P, Kloiber S, Czamara D, Lucae S, Hennings J et al. Polymorphisms within the metabotropic glutamate receptor 1 gene are associated with depression phenotypes. Psychoneuroendocrinology 2012; 37: 565–575.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank the participants and their families for their contribution to this research. Furthermore, we acknowledge Karine Lachapelle and Annie Levert from the laboratory of GAR for technical assistance. This work was funded through a grant from Genome Quebec.

Author information

Authors and Affiliations

Authors

Contributions

All individuals included as authors have contributed substantially to the scientific process by participating in the study design, execution and the redaction of the manuscript.

Corresponding authors

Correspondence to G Turecki or G A Rouleau.

Ethics declarations

Conflict of Interest

The authors declare no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cruceanu, C., Schmouth, JF., Torres-Platas, S.G. et al. Rare susceptibility variants for bipolar disorder suggest a role for G protein-coupled receptors. Mol Psychiatry 23, 2050–2056 (2018). https://doi.org/10.1038/mp.2017.223

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2017.223

This article is cited by

Search

Quick links